Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Unveiling the migration reactivity of bicyclic diaziridines: enantioselective synthesis of chiral pyrazolines

Zhili Liu, Lichao Ning, Bingqian Yang, Kaixuan Wang, Lili Lin* and Xiaoming Feng*
Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, P. R. China. E-mail: lililin@scu.edu.cn; xmfeng@scu.edu.cn

Received 1st July 2025 , Accepted 9th August 2025

First published on 11th August 2025


Abstract

Ring-opening/cyclization represents a classic reaction of bicyclic diaziridines. In this study, an unprecedented ring-opening/migration cascade process was discovered in the reaction between bicyclic diaziridines and donor–acceptor (D–A) cyclopropanes. By employing a chiral N,N′-dioxide/scandium(III) complex as the catalyst, a diverse array of chiral dihydro-1H-pyrazoles with a stereocenter in the side chain was efficiently synthesized featuring excellent ee values. Control experiments indicated that the substitution on the D–A cyclopropane is of critical importance in determining the cyclization or migration process. When combined with DFT calculations, a plausible reaction mechanism was proposed, which involves a key transition state. This work presents a novel method for accessing pyrazolines and broadens the scope of diaziridine chemistry.


Introduction

Bicyclic diaziridines, specifically 1,5-diazabicyclo[3.1.0]hexanes, are a distinct class of diaziridine compounds. These nitrogen-rich molecules contain a strained cis N,N-disubstituted diaziridine moiety.1 Due to this inherent structural feature, they are inclined to undergo ring opening, which can occur through either selective C–N or N–N cleavage (Scheme 1a). The C–N cleavage pathway, which results in the formation of 1,3-dipole azomethine imine intermediates,2 is well documented. These intermediates readily participate in annulation reactions with dipolarophiles. In 2020, our group disclosed an asymmetric (3 + 2) annulation reaction between diaziridines and chalcones, which was facilitated by a scandium(III) catalyst.3 More recently, in 2025, Guo and Xie put forward a copper(II)-catalyzed asymmetric (3 + 3) annulation of diaziridines and oxiranes.4 Conversely, N–N cleavage paves the way for the preparation of nitrogen-containing medium-sized rings. A notable example is Doyle's group's work in 2019. They reported a highly stereoselective formal [3 + 3] desymmetrization cycloaddition of diaziridines with enol diazo compounds to form bridged dinitrogen heterocycles through chiral copper catalysis.5
image file: d5sc04846j-s1.tif
Scheme 1 Enantioselective reactions of diaziridines and representative pyrazoline-incorporating derivatives.

Meanwhile, pyrazolines featuring a chiral center on the side chain are ubiquitous in bioactive molecules (Scheme 1b).6 Current methodologies for the asymmetric synthesis of pyrazolines primarily rely on two strategies (Scheme 1c): (1) organocatalytic cycloadditions between hydrazines/diazo compounds and α,β-unsaturated carbonyl compounds;7 (2) Bolm's formal [4 + 1] cycloaddition of azoalkenes and sulfur ylides promoted by a chiral copper/BINAP complex.8

However, both approaches exclusively install the chiral center within the pyrazoline ring system. Given the prevalence of side-chain chirality in pharmacologically relevant pyrazolines, the development of efficient synthetic methods to access such scaffolds remains an unmet challenge and a compelling area of research.

Herein, we report the unprecedented migration reactivity of 1,5-diaza-bicyclo[3.1.0]hexanes in the reaction with D–A cyclopropanes9 catalyzed by a chiral scandium catalyst (Scheme 1d). This protocol provides an efficient approach to access chiral 3-disubstituted pyrazolines featuring a chiral center on the side chain.

Before initiating the research using bicyclic diaziridines and D–A cyclopropanes as substrates, a (3 + 3) annulation is predicted. Our initial investigation using cyclopropane ester and 6-methoxyl-1,5-diazabicyclo-[3.1.0]hexane indeed afforded a (3 + 3) adduct in the presence of Sc(OTf)3 as a catalyst, which is consistent with the (3 + 3) addition reaction reported by Ivanova and Trushkov for cyclopropane esters reacting with diaziridines under Ni(ClO4)2 catalysis.10 However, when the ester group on the D–A cyclopropanes was simply changed to a ketone group, the unexpected 1,3-disubstituted pyrazoline was obtained as the product (Scheme 2). Notably, a benzyl group migration process occurred instead of cycloaddition.11 Although the yield is low, this presents an opportunity to develop an efficient synthetic method for chiral diaziridines featuring a chiral center on the side chain.


image file: d5sc04846j-s2.tif
Scheme 2 Discovery of migration reactivity.

Results and discussion

Then, the optimization of the reaction conditions was conducted (Table 1). Investigation of metal salts by complexing with chiral L-pipecolic acid-derived N,N′-dioxide L3-PiPr3 revealed that numerous metal salts, including Mg(OTf)2, MgCl2, and Ni(OTf)2, were ineffective in the reaction.12 Both yield and enantioselectivity remained low (Table 1, entries 1–3). Notably, rare-earth metal salts Y(OTf)3 and La(OTf)3 improved the enantioselectivity (Table 1, entries 4–5). Specifically, Sc(OTf)3 afforded 91% ee despite a modest yield of 27% (Table 1, entry 6). Ligand screening demonstrated that both the chiral skeleton and amide substituent significantly impacted the enantioselectivity. L-Proline-derived L3-PrPr3 reduced the enantioselectivity to 73% ee (Table 1, entry 7), while L-ramipril-derived L3-RaPr3 caused a drastic decrease to below 10% ee (Table 1, entry 8). Removal of the para-substituent on the amide benzene ring led to a reduction in enantioselectivity to 55% ee (Table 1, entry 9). Switching the solvent from 1,2-dichloroethane to 1,1,2,2-tetrachloroethane (TCE) and increasing the loading of 1a to 2.2 equivalents improved the yield from 27% to 46% (Table 1, entry 10). The addition of MgCl2 further enhanced the yield to 63%.
Table 1 Optimization of reaction conditionsa

image file: d5sc04846j-u1.tif

  Metal salt Ligand Add. Yield Ee/%
a The reactions were performed with metal salt/ligand (1[thin space (1/6-em)]:[thin space (1/6-em)]1, 10 mol%), 1a (0.2 mmol), and 2a (0.1 mmol), in 1,2-dichloroethane (1.0 mL) at 60 °C for 36 h. Isolated yield. The ee was determined by UPCC analysis on a chiral stationary phase.b 1,1,2,2-Tetrachloroethane (1.0 mL) as the solvent, 1a (2.2 equiv.).
1 Mg(OTf)2 L3-PiPr3 15 14
2 MgCl2 L3-PiPr3 12 15
3 Ni(OTf)2 L3-PiPr3 13 11
4 Y(OTf)3 L3-PiPr3 26 53
4 La(OTf)3 L3-PiPr3 18 49
5 Sc(OTf)3 L3-PiPr3 27 91
6 Sc(OTf)3 L3-PrPr3 26 73
8 Sc(OTf)3 L3-RaPr3 22 8
9 Sc(OTf)3 L3-PiPr2 22 55
10b Sc(OTf)3 L3-PiPr3 42 92
11b Sc(OTf)3 L3-PiPr3 MgCl2 63 92


While maintaining 92% ee (Table 1, entry 11). Further yield improvement was hindered by the formation of numerous byproducts, including those from benzyl group cleavage and the self-cyclization of D-A cyclopropanes.

With the optimized conditions established, the substrate scope was evaluated (Scheme 3). First, the scope of D–A cyclopropanes was investigated via reaction with diaziridine 2a. For ortho-substituted phenyl cyclopropyl ketones,13 F or Cl substitution exerted no significant effect on yield or enantioselectivity (3ab and 3ac). D–A cyclopropanes bearing electron-withdrawing or electron-donating substituents at the meta- or para-position of the aryl ring were efficiently converted to the corresponding products 3ad–3al with 34–60% yield and 89–93% ee. The 2-naphthyl substituted cyclopropyl ketone afforded product 3ao in 62% yield with 90% ee. A para-F substituted benzoyl group at the 1-position of cyclopropanes showed no obvious influence on the reaction (3ap). Notably, the methylphenyl group increased the enantioselectivity to 98% ee (3aq). The absolute configuration of 3ah was determined to be (R) by single-crystal X-ray diffraction analysis.14 In addition, bis-ester substituted cyclopropane was employed to react with diaziridine 2a under the optimized reaction conditions. The cycloaddition product was found in less than 10% yield with no migration product detected.


image file: d5sc04846j-s3.tif
Scheme 3 Substrate scope. Unless otherwise noted, all reactions were performed with 1 (0.22 mmol), 2 (0.1 mmol), Sc(OTf)3/L3-PiPr3 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, 10 mol%), and MgCl2 (30 mol%) in 1,1,2,2-tetrachloroethane (1.0 mL) at 60 °C for a defined amount of time. Isolated yields of the products were given. The ee values were determined by chiral UPCC analysis.

Subsequently, the scope of diaziridines was screened. Diaziridines bearing electron-withdrawing or electron-donating groups on their aryl rings were compatible, furnishing the desired products (3ba–3ka) in moderate yields (39–60%) with high enantioselectivities (85–95% ee). Efforts to enhance the yield by prolonging the reaction time were unsuccessful. The 2-naphthyl-substituted diaziridine 2m was also suitable, affording product 3ma in 40% yield with 85% ee. 2,3-Dimethyl and 2,4-dichloro substituents on the aryl ring of the diaziridine were also tolerated under this catalytic system (3la and 3na). The 2-thienyl-substituted diaziridine substrate 2p underwent smooth conversion, delivering the desired product in 54% yield with 92% ee. Diaziridines bearing a benzyl group with strong electron-withdrawing substituents, such as a p-nitro or p-trifluoromethyl group, failed to yield the corresponding products.

To demonstrate the synthetic utility of this methodology, a gram-scale synthesis of 3ah was performed. As illustrated in Scheme 4a, 8.8 mmol of cyclopropyl ketone 1h reacted smoothly with 4.0 mmol of diaziridine 2a under standard conditions, affording 1.16 g of 3ah in 56% yield with 92% ee. Oxidation with DDQ afforded the chiral product 4a in 92% yield with 89% ee. Furthermore, pyrazole and isoxazole products 5a and 6a were obtained in the presence of NH2NH2 and NH2OH in EtOH.


image file: d5sc04846j-s4.tif
Scheme 4 (a) Gram-scale synthesis and transformations of product 3ah; (b) cross experiment; (c) investigation of additive roles.

To elucidate the reaction mechanism, a cross experiment was conducted (Scheme 4b). When 1a was reacted with 2r and 3,3-dimethyl diaziridine 2i simultaneously, 3ia, 3ra, and cross-product 3aa were isolated, suggesting the involvement of a benzylic carbocation intermediate in the reaction pathway. To probe the roles of Mg(II) salt and the Sc(III)/L3-PiPr3 complex, several control experiments were performed. In the absence of L3-PiPr3, the reaction mixture became complex, with only trace amounts of product detected. Changing the anion of the additive from Cl to OTf or I caused a sharp decline in both yield and ee value (Scheme 4c, entries 2–3). Switching the additive cation to Ca2+ or Na+ reduced the yield but preserved excellent enantioselectivity. Additionally, using ScCl3·6H2O/L3-PiPr3 as the catalyst afforded the corresponding product 3aa in only 15% yield with 13% ee. These control experiments indicate that magnesium chloride facilitates the formation of the azomethine imine intermediate and is critical for achieving high yield and enantioselectivity in the reaction.

Furthermore, DFT calculations (Scheme 5) were performed to clarify the reaction mechanism. The two enantiomers of compound 1a coordinate with the catalyst, facilitating a nucleophilic attack on the cyclopropane carbon atom by the intermediate formed from the ring-opening product of 2a in the presence of magnesium chloride. This results in the opening of the cyclopropane ring and formation of intermediate int-1. The transformation proceeds via two possible transition states, ts-R and ts-S. Computational analysis indicates that ts-R is 1.2 kcal mol−1 lower in energy than ts-S. Structural analysis attributes this energy difference to significant steric hindrance between the phenyl group of the cyclopropane ring and the aryl substituent of the ligand's amide moiety in ts-S. int-2 undergoes a proton transfer to form intermediate int-3. int-3 undergoes benzyl cation release via transition state ts-2, with an associated activation barrier of 27 kcal mol−1, identifying this step as the rate-determining step of the reaction. We also performed calculations on the intermediate leading to the [3 + 3] cycloaddition product. Upon optimization, this intermediate was found to undergo spontaneous ring opening, indicating that it is energetically unstable and highlighting the difficulty of forming the [3 + 3] product under the current conditions. Subsequently, the benzyl cation attacks the carbon center of int-4 via transition state ts-3, forming intermediate int-5 with an activation barrier of only 5.5 kcal mol−1. A final proton transfer, MgCl2 and catalyst release then afford the observed product.


image file: d5sc04846j-s5.tif
Scheme 5 Plausible reaction mechanism.

Conclusions

In summary, we disclosed a benzyl migration process in the reaction of D–A cyclopropanes with 1,5-diazabicyclo[3.1.0]hexanes. The work not only uncovers a new reaction of diaziridines but also provides a novel method for the enantioselective synthesis of chiral pyrazole derivatives bearing a chiral center on the side chain. In addition, this study expands the frontiers of diaziridine chemistry, thereby opening up new avenues for the synthesis of chiral heterocyclic compounds and the exploration of cascade reaction mechanisms.

Author contributions

Z. L. L. performed experiments and prepared the manuscript and SI. L. C. N. conducted the DFT calculation. B. Q. Y. repeated some experiments. K. X. W. helped with modifying the paper and SI. L. L. L. and X. M. F. conceived and directed the project.

Conflicts of interest

There are no conflicts to declare.

Data availability

Further details of the experimental procedure, 1H, 13C{1H} and 19F{1H} NMR, HPLC spectra, SFC spectra, and X-ray crystallographic data for complex 3ah are available in the SI. See DOI: https://doi.org/10.1039/d5sc04846j.

Acknowledgements

We thank the National Key R&D Program of China (2023YFA1506700) and the National Natural Science Foundation of China (No. 22171189) for financial support. We are grateful to Dr Yuqiao Zhou from College of Chemistry, Sichuan University for the X-ray single-crystal diffraction analysis.

Notes and references

  1. For selected examples: (a) A. P. Molchanov, D. I. Sipkin, Y. B. Koptelov, J. Kopf and R. R. Kostikov, Russ. J. Org. Chem., 2003, 39, 1338–1345 CrossRef CAS; (b) A. P. Molchanov, D. I. Sipkin, Y. B. Koptelov and R. R. Kostikov, Eur. J. Org Chem., 2002, 2002, 453–456 CrossRef; (c) A. V. Shevtsov, V. V. Kuznetsov, A. A. Kislukhin, V. Y. Petukhova, Y. A. Strelenko, N. N. Makhova and K. A. Lyssenko, J. Heterocycl. Chem., 2006, 43, 881–888 CrossRef CAS; (d) Yu. S. Syroeshkina, L. L. Fershtat, V. V. Kachala, V. V. Kuznetsov and N. N. Makhova, Russ. Chem. Bull., 2010, 59, 1621–1630 CrossRef CAS; (e) Y. S. Syroeshkina, V. V. Kuznetsov, K. A. Lyssenko and N. N. Makhova, Russ. Chem. Bull., 2009, 58, 366–379 CrossRef CAS; (f) M. I. Pleshchev, N. V. Das Gupta, M. I. Struchkova, A. S. Goloveshkin, I. S. Bushmarinov, D. V. Khakimov and N. N. Makhova, Mendeleev Commun., 2015, 25, 188–190 CrossRef CAS; (g) A. P. Molchanov, M. M. Efremova, M. A. Kryukova and M. A. Kuznetsov, Beilstein J. Org. Chem., 2020, 16, 2679–2686 CrossRef PubMed; (h) J. Cortes Vazquez, J. Davis, V. N. Nesterov, H. Wang and W. Luo, Org. Lett., 2021, 23, 3136–3140 CrossRef CAS PubMed; (i) P. K. Maharana, T. Sarkar, S. Kar, S. K. Purkayastha, A. K. Guha and T. Punniyamurthy, J. Org. Chem., 2023, 88, 9447–9458 CrossRef CAS PubMed.
  2. For selected reviews: (a) R. Huisgen, Angew. Chem., Int. Ed., 1963, 2, 565–632 CrossRef; (b) R. Huisgen, Angew. Chem., Int. Ed., 1963, 2, 633–696 CrossRef; (c) B. K. Jose, A. Simon, N. Subrahmanian, P. Adhwithi and S. Mathai, J. Heterocycl. Chem., 2024, 61, 199–216 CrossRef CAS.
  3. H. P. Hu, J. X. Xu, F. Wang, S. X. Dong, X. H. Liu and X. M. Feng, Org. Lett., 2020, 22, 93–97 CrossRef CAS PubMed.
  4. Y. Hu, H. B. Yu, Y. Tian, M. S. Xie and H. M. Guo, Org. Lett., 2025, 27, 1310–1315 CrossRef PubMed.
  5. H. F. Zheng and M. P. Doyle, Angew. Chem., Int. Ed., 2019, 58, 12502–12506 CrossRef CAS PubMed.
  6. For selected reviews: (a) B. Varghese, S. N. Al-Busafi, F. O. Suliman and S. M. Z. Al-Kindy, RSC Adv., 2017, 7, 46999–47016 RSC; (b) B. Nehra, S. Rulhania, S. Jaswal, B. Kumar, G. Singh and V. Monga, Eur. J. Med. Chem., 2020, 205, 112666 CrossRef CAS PubMed; (c) R. Kumar, H. Singh, A. Mazumder, Salahuddin and R. K. Yadav, Top. Curr. Chem., 2023, 381, 12 CrossRef CAS PubMed.
  7. For selected examples: (a) T. Vahedpour, M. Hamzeh-Mivehroud, S. Hemmati and S. Dastmalchi, ChemistrySelect, 2021, 6, 6483–6506 CrossRef CAS; (b) O. Maké, I. Dez, V. Levacher and J. F. Briére, Angew. Chem., Int. Ed., 2010, 49, 7072–7075 CrossRef PubMed; (c) N. R. Campbell, B. Sun, R. P. Singh and L. Deng, Adv. Synth. Catal., 2011, 353, 3123–3128 CrossRef CAS PubMed; (d) M. Fernández, E. Reyes, J. L. Vicario, D. Badía and L. Carrillo, Adv. Synth. Catal., 2012, 354, 371–376 CrossRef; (e) X. X. Wu, B. Liu, Y. X. Zhang, M. Jeret, H. L. Wang, P. C. Zheng, S. Yang, B. A. Song and Y. R. Chi, Angew. Chem., Int. Ed., 2016, 55, 12280–12284 CrossRef CAS PubMed; (f) J. Sendra, E. Reyes, L. Prieto, E. Fernández and J. L. Vicario, Org. Lett., 2021, 23, 8738–8743 CrossRef CAS PubMed; (g) T. Kano, T. Hashimoto and K. Maruoka, J. Am. Chem. Soc., 2006, 128, 2174–2175 CrossRef CAS PubMed; (h) S. Müller and B. List, Angew. Chem., Int. Ed., 2009, 48, 9975–9978 CrossRef PubMed; (i) L. Lykke, B. D. Carlsen, R. S. Rambo and K. A. Jørgensen, J. Am. Chem. Soc., 2014, 136, 11296–11299 CrossRef CAS PubMed.
  8. J. R. Chen, W. R. Dong, M. Candy, F. F. Pan, M. Jörres and C. Bolm, J. Am. Chem. Soc., 2012, 134, 6924–6927 CrossRef CAS PubMed.
  9. For selected examples: (a) A. T. Parsons and J. S. Johnson, J. Am. Chem. Soc., 2009, 131, 3122–3123 CrossRef CAS PubMed; (b) D. C. Wang, M. S. Xie, H. M. Guo, G. R. Qu, M. C. Zhang and S. L. You, Angew. Chem., Int. Ed., 2016, 55, 14111–14115 CrossRef CAS PubMed; (c) J. Blom, A. Vidal-Albalat, J. Jørgensen, C. L. Barløse, K. S. Jessen, M. V. Iversen and K. A. Jørgensen, Angew. Chem., Int. Ed., 2017, 56, 11831–11835 CrossRef CAS PubMed; (d) Y. Y. Zhou, J. Li, L. Ling, S. H. Liao, X. L. Sun, Y. X. Li, L. J. Wang and Y. Tang, Angew. Chem., Int. Ed., 2013, 52, 1452–1456 CrossRef CAS PubMed; (e) H. Xu, J. L. Hu, L. Wang, S. Liao and Y. Tang, J. Am. Chem. Soc., 2015, 137, 8006–8009 CrossRef CAS PubMed; (f) L. Prieto, E. Sánchez-Díez, U. Uria, E. Reyes, L. Carrillo and J. L. Vicario, Adv. Synth. Catal., 2017, 359, 1678–1683 CrossRef CAS; (g) M. Bao and M. P. Doyle, Org. Lett., 2023, 25, 3029–3033 CrossRef CAS PubMed; (h) D. D. Borisov, D. N. Platonov, N. A. Sokolov, R. A. Novikov and Y. V Tomilov, Angew. Chem., Int. Ed., 2016, 55, 14111–14115 CrossRef PubMed; (i) A. H. Bansode, L. F. Yin, N. Deng, M. Afrasi, Y. Y. Zhu and M. Parasram, Angew. Chem., Int. Ed., 2025, 64, e202420485 Search PubMed; (j) S. Liao, X. L. Sun and Y. Tang, Acc. Chem. Res., 2014, 47, 2260–2272 CrossRef CAS PubMed; (k) V. Pirenne, B. Muriel and J. Waser, Chem. Rev., 2021, 121, 227–263 CrossRef CAS PubMed; (l) M. Lee, J. Heo, D. Kim and S. Chang, J. Am. Chem. Soc., 2022, 144, 3667–3675 CrossRef CAS PubMed; (m) I. Nakamura, M. Okamoto, Y. Sato and M. Terada, Angew. Chem., Int. Ed., 2012, 51, 10816–10819 CrossRef CAS PubMed.
  10. (a) A. O. Chagarovskiy, V. S. Vasin, V. V. Kuznetsov, O. A. Ivanova, V. B. Rybakov, A. N. Shumsky, N. N. Makhova and I. V. Trushkov, Angew. Chem., Int. Ed., 2018, 57, 10338–10342 CrossRef CAS PubMed; (b) S. S. Dai, X. J. Yang, R. Fang, A. M. Kirillov and L. Z. Yang, Org. Chem. Front., 2023, 10, 1948–1958 RSC.
  11. For selected reviews: (a) X. M. Zhang, Y. Q. Tu, F. M. Zhang, Z. H. Chen and S. H. Wang, Chem. Soc. Rev., 2017, 46, 2272–2305 RSC; (b) X. Wu, Z. Ma, T. Feng and C. Zhu, Chem. Soc. Rev., 2021, 50, 11577–11613 RSC; (c) F. Doraghi, S. Kermaninia, E. S. Ghalehsefid, B. Larijani and M. Mahdavi, RSC Adv., 2025, 15, 14691–14716 RSC; (d) Y. B. Liu, X. H. Liu and X. M. Feng, Chem. Sci., 2022, 13, 12290–12308 RSC.
  12. For selected reviews and examples N,N'-dioxide on ligands see: (a) X. H. Liu, L. L. Lin and X. M. Feng, Org. Chem. Front., 2014, 1, 298–302 RSC; (b) X. H. Liu, S. X. Dong, L. L. Lin and X. M. Feng, Chin. J. Chem., 2018, 36, 791–797 CrossRef CAS; (c) M. Y. Wang and W. Li, Chin. J. Chem., 2021, 39, 969–998 CrossRef CAS; (d) S. X. Dong, X. H. Liu and X. M. Feng, Acc. Chem. Res., 2022, 55, 415–428 CrossRef CAS PubMed; (e) X. H. Liu, H. F. Zheng, Y. Xia, L. L. Lin and X. M. Feng, Acc. Chem. Res., 2017, 50, 2621–2631 CrossRef CAS PubMed; (f) L. L. Lin, Y. Q. Zhou, W. D. Cao, S. X. Dong, X. H. Liu and X. M. Feng, Sci. Sin.: Chim., 2023, 53, 246–258 Search PubMed; (g) S. X. Dong, W. D. Cao, M. P. Pu, X. H. Liu and X. M. Feng, CCS Chem., 2023, 5, 2717–2735 CrossRef CAS; (h) Z. Yang, Z. Jiang, Z. Tan, H. Yu, X. M. Feng and X. H. Liu, Chem. Commun., 2024, 60, 10926–10929 RSC; (i) K. X. Wang, C. R. Xu, X. Y. Hu, Y. Q. Zhou, L. L. Lin and X. M. Feng, Chem. Commun., 2021, 57, 8917–8920 RSC; (j) M. Chen, L. Q. Yang, Y. Z. Li, Y. H. Qu, G. H. Pan, X. M. Feng and X. H. Liu, Sci. China:Chem., 2024, 67, 542–550 CrossRef CAS; (k) A. Y. Yihuo, M. P. Pu, Z. Tan, J. B. Liao, J. Q. Tan, Q. L. Zhou, X. H. Liu and X. M. Feng, Sci. China:Chem., 2024, 67, 2694–2700 CrossRef CAS; (l) W. D. Cao, X. H. Liu and X. M. Feng, Acc. Chem. Res., 2025, 58, 2496–2510,  DOI:10.1021/acs.accounts.5c00370; (m) X. F. Chen, Y. Q. Zhou, M. Yang, Y. T. Yang, W. D. Cao and X. M. Feng, Angew. Chem., Int. Ed., 2025, e202504676 Search PubMed; (n) H. K. Wang, L. J. Song, J. Huang, F. L. Wu, Z. Yang, Y. B. Liu, Y. D. Wu and X. M. Feng, Angew. Chem., Int. Ed., 2025, 64, e202500125 CrossRef CAS PubMed; (o) F. L. Wu, H. K. Wang, Z. W. Wu, Y. B. Liu and X. M. Feng, J. Am. Chem. Soc., 2025, 147, 16237–16247 CrossRef CAS PubMed; (p) Z. D. Yang, M. P. Pu, L. K. Yang, Y. Q. Zhou, H. D. Wu, B. S. Wang, X. M. Feng and X. H. Liu, Angew. Chem., Int. Ed., 2025, 64, e202505725 CrossRef CAS PubMed.
  13. (a) Y. Xia, X. H. Liu and X. M. Feng, Angew. Chem., Int. Ed., 2021, 60, 9192–9204 CrossRef CAS PubMed; (b) Y. Xia, F. Z. Chang, L. L. Lin, Y. L. Xu, X. H. Liu and X. M. Feng, Org. Chem. Front., 2018, 5, 1293–1296 RSC; (c) F. Z. Chang, B. Shen, S. J. Wang, L. L. Lin and X. M. Feng, Chem. Commun., 2020, 56, 13429–13432 RSC.
  14. CCDC 2331716, [3ah] contains the supplementary crystallo-graphic data for this paper. These data are provided free of charge by the joint Cambridge Crystallographic Data Centre and Fachinformationszentrum Karlsruhe Access Structures service.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.